Barcode
Barcode Nanotech is a biotechnology company founded in 2017 that develops and optimizes selective delivery vehicles for RNA and DNA-based therapeutics and vaccines. Their proprietary platform uses nanoparticles formulated with unique lipids to enable precise targeting and effective encapsulation of RNA/DNA drugs, addressing a major challenge in RNA therapeutics by delivering molecules to specific tissues and cells beyond the liver. The company employs an AI-powered in vivo mass screening platform to identify optimal lipid-based nanoparticles for various indications including hard-to-treat cancers and metabolic diseases. Barcode Nanotech partners with pharmaceutical companies to advance next-generation RNA therapeutics, leveraging its extensive library of novel lipids and screening capabilities to enhance drug activity at target sites, positioning itself as a key player in the RNA delivery space.
Barcode
Barcode Nanotech is a biotechnology company founded in 2017 that develops and optimizes selective delivery vehicles for RNA and DNA-based therapeutics and vaccines. Their proprietary platform uses nanoparticles formulated with unique lipids to enable precise targeting and effective encapsulation of RNA/DNA drugs, addressing a major challenge in RNA therapeutics by delivering molecules to specific tissues and cells beyond the liver. The company employs an AI-powered in vivo mass screening platform to identify optimal lipid-based nanoparticles for various indications including hard-to-treat cancers and metabolic diseases. Barcode Nanotech partners with pharmaceutical companies to advance next-generation RNA therapeutics, leveraging its extensive library of novel lipids and screening capabilities to enhance drug activity at target sites, positioning itself as a key player in the RNA delivery space.